GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with coronary CT angiography

Chalfont St. Giles, UK, 2 May 2017 – Broadening its range of diagnostic options for clinicians and their patients, GE Healthcare announced today that it has received an indication approval from the U.S. Food and Drug Administration (FDA) for its imaging agent Visipaque™ (iodixanol) Injection. Visipaque 320 mg Iodine/mL is an iso-osmolar agent that is... Read more

Twist Bioscience Appoints Chief Ethics and Compliance Officer

SAN FRANCISCO, Calif. – May 1, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, today announced the appointment of Mark Daniels to the newly-created position of chief ethics and compliance officer. Mr. Daniels will maintain his current position as Twist Bioscience’s general counsel, and in his expanded role,... Read more

BASi Announces Appointment of Scientific Advisor

FOR MORE INFORMATION: Company Contact: Jill Blumhoff Chief Financial Officer & Vice President of Finance Phone: 765.497.8381 jblumhoff@BASinc.com WEST LAFAYETTE, IN, May 1, 2017 — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced its Board of Directors has appointed Dr. Peter T. Kissinger, founder and former Executive Chairman and CEO of BASi, as... Read more

Chairman to Take Medical Leave of Absence

28/04/2017 The Board of Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, announces that Dr John Hughes, non-executive Chairman, has taken leave of absence in order to undergo medical treatment. Russell King, Senior Independent Director, will assume the Chair until John’s return or the appointment of his successor on completion of the... Read more

Invitation to Roche Analyst Event at ASCO 2017

Basel, 28 April 2017 Invitation to Roche Analyst Event at ASCO 2017 Monday, 5 June 2017, 5:15pm CDT We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (2 – 6... Read more

Chairman to take medical leave of absence

The Board of Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, announces that Dr John Hughes, non-executive Chairman, has taken leave of absence in order to undergo medical treatment. Russell King, Senior Independent Director, will assume the Chair until John’s return or the appointment of his successor on completion of the recruitment... Read more

The VWR Foundation Approves Grants to Enable Science Education

RADNOR, Pa., April 27, 2017 /PRNewswire/ — The VWR Foundation, a charitable organization dedicated to giving back to the science community, distributed six grants totaling over $44,000 during its Board Meeting earlier this month. Five of the grants were awarded to organizations that are new to the VWR Foundation, and all of them support science education... Read more

Bruker Corporation to Present at the 42nd Annual Deutsche Bank Health Care Conference

BILLERICA, Mass., April 27, 2017 /PRNewswire/ — Bruker Corporation (NASDAQ: BRKR) announced today it will present at the 42nd annual Deutsche Bank Health Care Conference at The InterContinental Hotel, 510 Atlantic Avenue, Boston. Frank Laukien, Chairman, President & CEO will participate in a “fireside chat” Q&A session on behalf of the company on Thursday, May... Read more

MTS Systems to Present at Wells Fargo Industrials Conference

EDEN PRAIRIE, MN, April 27, 2017 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and sensors, today announced that Dr. Jeffrey Graves, President and CEO, will make a presentation to the investment community at the 2017 Wells Fargo Industrials Conference on Wednesday, May 10, at 10:00 a.m. ET, at the New... Read more